These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5984730)

  • 1. [Antibody synthesis in vitro. 3. Formation of an antibody analogous product (AAP) following stimulation with influenza virus antigen].
    Drescher J; Jacherts D
    Zentralbl Bakteriol Orig; 1966 Mar; 199(3):315-28. PubMed ID: 5984730
    [No Abstract]   [Full Text] [Related]  

  • 2. The antigenic subunits of influenza viruses. II. The spectrum of cross reactions.
    Fazekas de Saint Groth
    J Immunol; 1969 Nov; 103(5):1107-15. PubMed ID: 5350970
    [No Abstract]   [Full Text] [Related]  

  • 3. Communications. Antigenic relationship between the equine and the Hong Kong human variant of influenza type A2 virus.
    Kasel JA; Fulk RV; Couch RB
    J Immunol; 1969 Feb; 102(2):530-2. PubMed ID: 5812724
    [No Abstract]   [Full Text] [Related]  

  • 4. Method for detecting influenza virus sensibilizing antigen by the antibody neutalization test.
    Avrorova RI; Levi MI
    Acta Virol; 1968 Mar; 12(2):167-70. PubMed ID: 4384406
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the antigenic differences between influenza type A2 virus strains.
    Tokuda M; Bolli P; Imai J
    Acta Sch Med Univ Kioto; 1970 Mar; 40(3):239-53. PubMed ID: 5447689
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of -type inhibitor of influenza virus haemagglutination in human serum.
    Caliò R
    Boll Ist Sieroter Milan; 1972; 51(3):200-10. PubMed ID: 4120020
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of type B influenza in Kiev in 1963.
    Yatel' TP
    Fed Proc Transl Suppl; 1966; 25(1):135-8. PubMed ID: 5215786
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetics of specific in vitro antibody production following influenza immunization.
    Mitchell DM; Fitzharris P; Knight RA; Schild GC
    Clin Exp Immunol; 1982 May; 48(2):491-8. PubMed ID: 7105493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of the method of plaque formation of influenza virus and its application to neutralization tests.
    Kan T; Koyama K; Takaku K; Takahashi M; Kunita N
    Biken J; 1970 Sep; 13(3):185-92. PubMed ID: 4992055
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies with the influenza virus strain A2 Moscow 57-65].
    Herzberg K; Reuss K
    Zentralbl Bakteriol Orig; 1968 Mar; 206(2):139-49. PubMed ID: 5707653
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo studies of infectious influenza virus-antibody complex.
    Zalan E; Labzoffsky NA
    Acta Virol; 1973 May; 17(3):215-9. PubMed ID: 4147140
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of tissue cultures for the separation of V and S influenza antigen.
    Suharto ; Tůmová B
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(2):254-6. PubMed ID: 4977285
    [No Abstract]   [Full Text] [Related]  

  • 13. The antigenic subunits of influenza viruses. I. The homologous antibody response.
    Fazekas de Saint Groth ; Webster RG; Davenport FM
    J Immunol; 1969 Nov; 103(5):1099-106. PubMed ID: 5350969
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of antibody in the canine tracheal pouch after local and systemic influenza immunization.
    Lieberman P; Berlin BS; Metzger J; Patterson R
    J Immunol; 1972 Oct; 109(4):864-9. PubMed ID: 5074334
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of cross-reaction of selected influenza virus A2 strains isolated from 1957 to 1968, as determined by use of a photometric hemagglutination-inhibition test.
    Drescher J
    Am J Epidemiol; 1972 Jun; 95(6):549-56. PubMed ID: 5029823
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the rinderpest virus under application of cell cultures].
    Liess B
    Arch Exp Veterinarmed; 1966 Apr; 20(2):203-57. PubMed ID: 4869805
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of antigenic structure of influenza A2 virus strains isolated in the 1965 epidemic.
    Ritova VV; Schastny EI; Oganesyan OT; Larionov AC
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(1):18-26. PubMed ID: 6070330
    [No Abstract]   [Full Text] [Related]  

  • 18. Formation and persistence of neutralizing, complement-fixing and haemagglutination-inhibiting antibodies in Tahyna virus experimental infection of rabbits.
    Málková D; Kolman JM; Marhoul Z
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(4):482-92. PubMed ID: 5391989
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological and antigenic characteristics of an A2 influenza virus isolated in 1965.
    Walder R; Hsiung GD
    Public Health Rep (1896); 1967 Aug; 82(8):689-96. PubMed ID: 4962117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.